SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

NCT07342621 · clinicaltrials.gov ↗

RECRUITING

Status

41

Enrollment

NETWORK

Sponsor class

Conditions

Cow's Milk Protein Allergy (CMPA)
Food Hypersensitivity
Infant Nutrition Disorders
Gut Microbiota

Sponsor

Outcomes'10